PREZCOBIX

Launch

darunavir and cobicistat

NDAORALTABLET, FOR SUSPENSION
Approved
Feb 2026
Lifecycle
Launch
Competitive Pressure
30/100
Clinical Trials
2

Clinical Trials (2)

NCT05378906Phase 1Completed

A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Compared to the Co-administration of the Separate Available Formulations of Darunavir and Cobicistat Under Fed Conditions in Healthy Participants

Started Jun 2022
32 enrolled
Healthy
NCT00855335Phase 3Completed

A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women

Started Apr 2009
77 enrolled
HIVHIV InfectionsPregnancy